Association between nicotine withdrawal and reward responsiveness in humans and rats

JAMA Psychiatry

Volumn 71, Issue 11, 2014, Pages 1238-1245

  Pergadia, Michele L ^a,b   Der Avakian, Andre ^c   D'Souza, Manoranjan S ^c   Madden, Pamela A F ^a   Heath, Andrew C ^a   Shiffman, Saul ^d   Markou, Athina ^c   Pizzagalli, Diego A ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; SODIUM CHLORIDE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NONHUMAN; RAT; REINFORCEMENT; REWARD; SMOKING; SMOKING CESSATION; ANIMAL; CLINICAL TRIAL; DEPRESSION; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; PSYCHOLOGY; WITHDRAWAL SYNDROME; YOUNG ADULT;

ADULT; ANIMALS; CONDITIONING, OPERANT; DEPRESSION; HUMANS; MALE; NICOTINE; RATS; REWARD; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84923689735     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.1016     Document Type: Article

References (61)

1. Centers for Disease Control and Prevention (CDC). Cigarette smoking-attributable morbidity: United States, 2000. Morbidity and MortalityWeekly. 2003;52(35):842-844.
2. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591-608.
3. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? a randomized clinical trial. J Consult Clin Psychol. 2006;74(6):1153-1161.
4. PergadiaML, Agrawal A, Heath AC, Martin NG, Bucholz KK, Madden PA. Nicotine withdrawal symptoms in adolescent and adult twins. Twin Res Hum Genet. 2010;13(4):359-369.
5. Cummings KM, Jaén CR, Giovino G. Circumstances surrounding relapse in a group of recent exsmokers. Prev Med. 1985;14(2):195-202.
6. Hughes JR. Clinical significance of tobacco withdrawal. Nicotine Tob Res. 2006;8(2):153-156.
7. Piasecki TM, Fiore MC, Baker TB. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol. 1998;107(2):238-251.
8. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics, II: improved tests of withdrawal-relapse relations. J Abnorm Psychol. 2003;112(1):14-27.
9. Donny EC, Chaudhri N, Caggiula AR, et al. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl). 2003;169(1):68-76.
10. Caggiula AR, Donny EC, PalmatierMI, Liu X, Chaudhri N, Sved AF. The role of nicotine in smoking: a dual-reinforcement model. Nebr Symp Motiv. 2009;55:91-109.
11. Asgaard GL, Gilbert DG, Malpass D, Sugai C, Dillon A. Nicotine primes attention to competing affective stimuli in the context of salient alternatives. Exp Clin Psychopharmacol. 2010;18(1):51-60.
12. Gilbert DG, Carlson JM, Riise H, Rabinovich NE, Sugai C, Froeliger B. Effects of nicotine and depressive traits on affective priming of lateralized emotional word identification. Exp Clin Psychopharmacol. 2008;16(4):293-300.
13. Gilbert DG, Rabinovich NE, Malpass D, et al. Effects of nicotine on affect are moderated by stressor proximity and frequency, positive alternatives, and smoker status. Nicotine Tob Res. 2008;10(7):1171-1183.
14. al-Adawi S, Powell J. The influence of smoking on reward responsiveness and cognitive functions: a natural experiment. Addiction. 1997;92(12):1773-1782.
15. Dawkins L, Powell J. Effects of nicotine and alcohol on affective responses to emotionally toned film clips. Psychopharmacology (Berl). 2011;216(2): 197-205.
16. Powell J, Dawkins L, Davis RE. Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry. 2002;51(2):151-163.
17. Powell JH, Pickering AD, Dawkins L,West R, Powell JF. Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict Behav. 2004;29(7):1407-1426.
18. Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE. A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence. Biol Psychiatry. 2008;63(11):1061-1065.
19. Epping-Jordan MP,Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998; 393(6680):76-79.
20. Watkins SS, Stinus L, Koob GF, Markou A. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther. 2000;292(3):1053-1064.
21. Kenny PJ, Gasparini F, Markou A. Group II metabotropic and alpha-amino-3-hydroxy-5- methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther. 2003;306 (3):1068-1076.
22. Der-Avakian A, Markou A.Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats. Behav Pharmacol. 2010;21 (4):359-368.
23. LeSage MG, Burroughs D, Pentel PR. Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. Pharmacol Biochem Behav. 2006; 83(4):585-591.
24. WeaverMT, Sweitzer M, Coddington S, et al. Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats. Nicotine Tob Res. 2012;14(7):824-832.
25. Dawkins L, Powell JH, Pickering A, Powell J, West R. Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction. 2009;104(5):850-858.
26. Kalamboka N, Remington B, Glautier S. Nicotine withdrawal and reward responsivity in a card-sorting task. Psychopharmacology (Berl). 2009;204(1):155-163.
27. Pizzagalli DA, Jahn AL, O'Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry. 2005;57(4):319-327.
28. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, FavaM. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res. 2008;43(1):76-87.
29. Pizzagalli DA, Bogdan R, Ratner KG, Jahn AL. Increased perceived stress is associated with blunted hedonic capacity: potential implications for depression research. Behav Res Ther. 2007;45(11): 2742-2753.
30. Der-Avakian A, D'Souza MS, Pizzagalli DA, Markou A. Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research. Transl Psychiatry. 2013;3:e297.
31. Vrieze E, Pizzagalli DA, Demyttenaere K, et al. Reduced reward learning predicts outcome in major depressive disorder. Biol Psychiatry. 2013;73(7): 639-645.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. ed 4 Washington, DC: American Psychiatric Association; 1994.
33. Glassman AH, Stetner F,Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA. 1988; 259(19):2863-2866.
34. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115.
35. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry. 1990;31(4):350-354.
36. Madden PA, Bucholz KK, Dinwiddie SH, et al. Nicotine withdrawal in women. Addiction. 1997;92 (7):889-902.
37. Xian H, Scherrer JF, Madden PA, et al. Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychol Med. 2005;35(3):409-419.
38. Japuntich SJ, Smith SS, Jorenby DE, Piper ME, Fiore MC, Baker TB. Depression predicts smoking early but not late in a quit attempt. Nicotine Tob Res. 2007;9(6):677-686.
39. Leventhal AM,Waters AJ, Kahler CW, Ray LA, Sussman S. Relations between anhedonia and smoking motivation. Nicotine Tob Res. 2009;11(9): 1047-1054.
40. Cook J, Spring B,McChargue D, Doran N. Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report. Nicotine Tob Res. 2010;12(9):978-982.
41. Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998;18(3):135-174.
42. Gilbert DG. Smoking: Individual Differences, Psychopathology, and Emotion.Washington, DC: Taylor and Francis; 1995.
43. Cook JW, Spring B,McChargue D. Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl). 2007;192(1):87-95.
44. Spring B, Cook JW, Appelhans B, et al. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl). 2008;196(3): 461-471.
45. Leventhal AM, MunafòM, Tidey JW, et al. Anhedonia predicts altered processing of happy faces in abstinent cigarette smokers. Psychopharmacology (Berl). 2012;222(2):343-351.
46. Spring B, Pingitore R, McChargue DE. Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry. 2003;160(2):316-322.
47. Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, ShadelWG. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology (Berl). 2006;184(3-4):637-644.
48. Westman EC, Behm FM, Simel DL, Rose JE. Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med. 1997;157(3):335-340.
49. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29-38.
50. Bucholz KK, Cadoret R, Cloninger CR, et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol. 1994;55(2): 149-158.
51. Cottler LB, Robins LN, Grant BF, et al. The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues: the WHO/ADAMHA Field Trial. Br J Psychiatry. 1991; 159:653-658.
52. McNair DM, Lorr M, Droppelman LF. Manual for the Profile of Mood States. San Diego, CA: Education and Industrial Testing Service; 1971.
53. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol. 1999;55(1):79-86.
54. Pizzagalli DA, Goetz E, Ostacher M, Iosifescu DV, Perlis RH. Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task. Biol Psychiatry. 2008;64 (2):162-168.
55. Parrott AC. Stress modulation over the day in cigarette smokers. Addiction. 1995;90(2):233-244.
56. Ulrich YM, Hargreaves KM, Flores CM. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites. Neuropharmacology. 1997;36(8):1119-1125.
57. Benwell ME, Balfour DJ, Anderson JM. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J Neurochem. 1988;50(4):1243-1247.
58. Small E, Shah HP, Davenport JJ, et al. Tobacco smoke exposure induces nicotine dependence in rats. Psychopharmacology (Berl). 2010;208(1):143-158.
59. Semenova S, Markou A. Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Biol Psychiatry. 2003;54(11):1249-1264.
60. Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology. 2009; 34(1):74-89.
61. Hyman SE, FentonWS. Medicine: what are the right targets for psychopharmacology? Science. 2003;299(5605):350-351.